Clinical Trial Update: The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the impact of Compound Danshen Dropping Pills (CDDP) on post-myocardial infarction ventricular remodeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Ventricular Remodeling

Drugs mentioned

• Compound Danshen Dropping Pills

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Myocardial Infarction | Phase 4 | Status: UNKNOWN